Handelsbanken Fonder
IOVA icon

Handelsbanken Fonder’s Iovance Biotherapeutics IOVA Stock Holding History

Handelsbanken Fonder’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-96,900
Closed -$210K – 1524
2025
Q3 		$210K Hold
96,900
– – ﹤0.01% 1480
2025
Q2 		$167K Buy
96,900
+24,200
+33% +$60.2K ﹤0.01% 1502
2025
Q1 		$242K Hold
72,700
– – ﹤0.01% 1461
2024
Q4 		$538K Sell
72,700
-2,100
-3% -$19.5K ﹤0.01% 1253
2024
Q3 		$702K Buy
74,800
+11,500
+18% +$109K ﹤0.01% 1092
2024
Q2 		$508K Sell
63,300
-155,600
-71% -$1.67M ﹤0.01% 1149
2024
Q1 		$3.24M Buy
218,900
+163,200
+293% +$1.9M 0.01% 504
2023
Q4 		$453K Buy
55,700
+26,500
+91% +$139K ﹤0.01% 1199
2023
Q3 		$133K Hold
29,200
– – ﹤0.01% 1525
2023
Q2 		$206K Buy
29,200
+4,300
+17% +$30.8K ﹤0.01% 1488
2023
Q1 		$152K Hold
24,900
– – ﹤0.01% 1495
2022
Q4 		$159K Hold
24,900
– – ﹤0.01% 1468
2022
Q3 		$239K Hold
24,900
– – ﹤0.01% 1365
2022
Q2 		$275K Hold
24,900
– – ﹤0.01% 1370
2022
Q1 		$415K Hold
24,900
– – ﹤0.01% 1325
2021
Q4 		$475K Hold
24,900
– – ﹤0.01% 1384
2021
Q3 		$614K Hold
24,900
– – ﹤0.01% 1214
2021
Q2 		$648K Hold
24,900
– – ﹤0.01% 1190
2021
Q1 		$788K Hold
24,900
– – ﹤0.01% 958
2020
Q4 		$1.16M Buy
24,900
+4,400
+21% +$175K 0.01% 761
2020
Q3 		$675K Hold
20,500
– – ﹤0.01% 854
2020
Q2 		$563K Buy
+20,500
New +$674K ﹤0.01% 913

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Handelsbanken Fonder's IOVA Position: Q4 2025 in Review

Handelsbanken Fonder sold out of Iovance Biotherapeutics (IOVA) in Q4 2025, closing a stake of 96,900 shares — an estimated $210K sold.

Handelsbanken Fonder first reported a position in IOVA in Q2 2020 and held it in 22 quarters. The position peaked at $3.24M in Q1 2024. 264 funds tracked by Wall St. Rank hold IOVA as of Q4 2025.

  • Handelsbanken Fonder reported no remaining Iovance Biotherapeutics position as of Q4 2025 after selling out during the quarter.
  • Handelsbanken Fonder sold 96,900 Iovance Biotherapeutics shares in Q4 2025, an estimated $210K.
  • Handelsbanken Fonder first reported a position in Iovance Biotherapeutics in Q2 2020 and held it in 22 quarters.
  • Handelsbanken Fonder's Iovance Biotherapeutics position peaked at $3.24M in Q1 2024.
  • 264 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2025.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.